Effect of Ayurvedic medicines on patients of breast cancer.

Role of Stanya shodhak mahakashaya and Amritbhallatak on tumour markers of breast carcinoma after conventional anticancer therapy:A single arm clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032560

Enrollment

Registered

2021-04-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Stanya shodhak mahakshaya and Amritbhallatak aveleha: Amritbhallatak aveleha 1 tsp twice a day with milk Route-oral administration Stanya shodhak mahakshaya kwath-40ml empty stomach tw

Eligibility

Inclusion criteria

Inclusion criteria: Female patient between the age grouop of 30 to 70 years having breast carcinoma. patient willing to sign the conscent form.

Exclusion criteria

Exclusion criteria: patient suffering from major systemic illness like diabetes,Hypertension,renal failure,IHD,MI

Design outcomes

Primary

Measure	Time frame
Change in tumour marker of breast carcinoma.Timepoint: 4 WEEKS	—

Secondary

Measure	Time frame
change in clinical manifestations od carcinoma of breast. Change in qol of the studied patient of carcinoma of breast.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr sharad porte

National institute of ayurveda jaipur

sharad.agad@nia.edu.in9024266338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026